CPTAC Acute Myeloid Leukemia Baseline Form

Preferred Label : CPTAC Acute Myeloid Leukemia Baseline Form;

NCI Metathesaurus CUI : CL951373;

Details

Origin ID

C159339;

UMLS CUI

C5204368;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
subset_includes_concept
- 3q Abnormality [NCIt concept]
- ANPEP Negative [NCIt concept]
- ANPEP Positive [NCIt concept]
- Abnormal [NCIt concept]
- Absolute Basophil Count [NCIt concept]
- Activating RAS Mutation [NCIt concept]
- Acute Basophilic Leukemia [NCIt concept]
- Acute Erythroid Leukemia [NCIt concept]
- Acute Megakaryoblastic Leukemia [NCIt concept]
- Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Acute Monocytic Leukemia [NCIt concept]
- Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 [NCIt concept]
- Acute Myeloid Leukemia Not Otherwise Specified [NCIt concept]
- Acute Myeloid Leukemia with CEBPA Mutation [NCIt concept]
- Acute Myeloid Leukemia with Maturation [NCIt concept]
- Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Acute Myeloid Leukemia with NPM1 Mutation [NCIt concept]
- Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 [NCIt concept]
- Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM [NCIt concept]
- Acute Myeloid Leukemia with t(6;9)(p22.3;q34.1); DEK-NUP214 [NCIt concept]
- Acute Myeloid Leukemia with t(8;21)(q22; q22.1); RUNX1-RUNX1T1 [NCIt concept]
- Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A [NCIt concept]
- Acute Myeloid Leukemia without Maturation [NCIt concept]
- Acute Myeloid Leukemia, Myelodysplasia-Related [NCIt concept]
- Acute Myelomonocytic Leukemia [NCIt concept]
- Acute Myelomonocytic Leukemia with Abnormal Eosinophils [NCIt concept]
- Acute Panmyelosis with Myelofibrosis [NCIt concept]
- Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA [NCIt concept]
- Additional Molecular Studies Were Not Performed [NCIt concept]
- Additional Molecular Studies Were Performed [NCIt concept]
- Adult Acute Monoblastic and Monocytic Leukemia [NCIt concept]
- Adult Acute Myeloid Leukemia with Minimal Differentiation [NCIt concept]
- Adult Acute Myeloid Leukemia without Maturation [NCIt concept]
- Age at Initial Pathologic Diagnosis [NCIt concept]
- Ancillary Study [NCIt concept]
- BCR-ABL1 Fusion Protein Expression [NCIt concept]
- BCR/ABL1 Fusion Gene [NCIt concept]
- Billion per Liter [NCIt concept]
- Blast Count [NCIt concept]
- Blood Sample [NCIt concept]
- Bone Marrow [NCIt concept]
- Bone Marrow Aspirate [NCIt concept]
- Bone Marrow Aspirate Immunophenotype & Cytochemistry [NCIt concept]
- Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed [NCIt concept]
- Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Performed [NCIt concept]
- Bone Marrow Differential Count within 24 Hours of Banking [NCIt concept]
- CBFB Gene Rearrangement [NCIt concept]
- CD11c Negative [NCIt concept]
- CD11c Positive [NCIt concept]
- CD14 Negative [NCIt concept]
- CD14 Positive [NCIt concept]
- CD15 Negative [NCIt concept]
- CD15 Positive [NCIt concept]
- CD19 Negative [NCIt concept]
- CD19 Positive [NCIt concept]
- CD20 Negative [NCIt concept]
- CD20 Positive [NCIt concept]
- CD22 Negative [NCIt concept]
- CD22 Positive [NCIt concept]
- CD25 Negative [NCIt concept]
- CD3 Negative [NCIt concept]
- CD3 Positive [NCIt concept]
- CD33 Negative [NCIt concept]
- CD33 Positive [NCIt concept]
- CD34 Negative [NCIt concept]
- CD34 Positive [NCIt concept]
- CD36 Negative [NCIt concept]
- CD36 Positive [NCIt concept]
- CD38 Negative [NCIt concept]
- CD38 Positive [NCIt concept]
- CD4 Negative [NCIt concept]
- CD4 Positive [NCIt concept]
- CD5 Negative [NCIt concept]
- CD5 Positive [NCIt concept]
- CD65 Negative [NCIt concept]
- CD65 Positive [NCIt concept]
- CD7 Negative [NCIt concept]
- CD7 Positive [NCIt concept]
- CD79A Negative [NCIt concept]
- CD79A Positive [NCIt concept]
- CD8 Negative [NCIt concept]
- CD8 Positive [NCIt concept]
- CDR Entry Completed by (signature) [NCIt concept]
- CEBPA Gene Mutation [NCIt concept]
- CPTAC Case Identifier [NCIt concept]
- Cellularity Measurement [NCIt concept]
- Check all that Apply [NCIt concept]
- Chromosome 5 Abnormality [NCIt concept]
- Chromosome 7 Abnormality [NCIt concept]
- Classified by FAB Only [NCIt concept]
- Classified by World Health Organization Only [NCIt concept]
- Comment [NCIt concept]
- Complete Blood Count from Clinical Peripheral Blood (Within 24 Hours of Banking) [NCIt concept]
- Complex Karyotype [NCIt concept]
- Consolidation Therapy [NCIt concept]
- Core Biopsy [NCIt concept]
- Cytogenetic Abnormalities Not Detected [NCIt concept]
- Cytogenetic Abnormality [NCIt concept]
- Cytogenetic Abnormality Positive by FISH [NCIt concept]
- Cytogenetic Risk Group-CALGB Criteria for AML [NCIt concept]
- Cytoplasmic CD3 Negative [NCIt concept]
- Cytoplasmic CD3 Positive [NCIt concept]
- Cytoplasmic Nucleophosmin Expression [NCIt concept]
- DNTT Negative [NCIt concept]
- DNTT Positive [NCIt concept]
- Date and Method of Initial Pathologic Diagnosis [NCIt concept]
- Date of Therapeutic Procedure [NCIt concept]
- ECOG Performance Status 0 [NCIt concept]
- ECOG Performance Status 1 [NCIt concept]
- ECOG Performance Status 2 [NCIt concept]
- ECOG Performance Status 3 [NCIt concept]
- ECOG Performance Status 4 [NCIt concept]
- ECOG Performance Status not Evaluated, not Provided or Available [NCIt concept]
- ENO2 Negative [NCIt concept]
- ENO2 Positive [NCIt concept]
- ERG Gene Mutation [NCIt concept]
- ETV6/RUNX1 Fusion Gene [NCIt concept]
- Eosinophil Count [NCIt concept]
- Erythrocyte Sedimentation Rate Measurement [NCIt concept]
- Event During Procedure [NCIt concept]
- FCER2 Negative [NCIt concept]
- FCER2 Positive [NCIt concept]
- FCGR1A Negative [NCIt concept]
- FCGR1A Positive [NCIt concept]
- FLT3 Gene Mutation [NCIt concept]
- FMC7 Negative [NCIt concept]
- FMC7 Positive [NCIt concept]
- Favorable CALGB Criteria [NCIt concept]
- Fluorescence In Situ Hybridization Was Not Performed [NCIt concept]
- Fluorescence In Situ Hybridization Was Performed [NCIt concept]
- Form Completed by (Signature) [NCIt concept]
- French-American-British Classification [NCIt concept]
- GATA1 Gene Mutation [NCIt concept]
- Gain of Chromosome 8 [NCIt concept]
- Gain of Chromosome 9 [NCIt concept]
- Gram per Deciliter [NCIt concept]
- HLA-DR Negative [NCIt concept]
- HLA-DR Positive [NCIt concept]
- Hematocrit Measurement [NCIt concept]
- Hemoglobin Measurement [NCIt concept]
- IDH1 NP_005887.2:p.R132X [NCIt concept]
- IDH2 NP_002159.2:p.R140X [NCIt concept]
- IDH2 NP_002159.2:p.R172X [NCIt concept]
- IGK Negative [NCIt concept]
- IGK Positive [NCIt concept]
- IL2RA Positive [NCIt concept]
- ITGAD Negative [NCIt concept]
- ITGAD Positive [NCIt concept]
- If Other, Specify [NCIt concept]
- Induction Therapy [NCIt concept]
- Initial Cancer Diagnosis Date [NCIt concept]
- Initial Pathologic Diagnosis Method [NCIt concept]
- Intermediate CALGB Criteria [NCIt concept]
- JAK2 Gene Mutation [NCIt concept]
- JAK3 Gene Mutation [NCIt concept]
- KIT Gene Mutation [NCIt concept]
- KIT Negative [NCIt concept]
- KIT Positive [NCIt concept]
- KMT2A Gene Rearrangement [NCIt concept]
- Karnofsky Performance Status 0 [NCIt concept]
- Karnofsky Performance Status 10 [NCIt concept]
- Karnofsky Performance Status 100 [NCIt concept]
- Karnofsky Performance Status 20 [NCIt concept]
- Karnofsky Performance Status 30 [NCIt concept]
- Karnofsky Performance Status 40 [NCIt concept]
- Karnofsky Performance Status 50 [NCIt concept]
- Karnofsky Performance Status 60 [NCIt concept]
- Karnofsky Performance Status 70 [NCIt concept]
- Karnofsky Performance Status 80 [NCIt concept]
- Karnofsky Performance Status 90 [NCIt concept]
- Karnofsky Performance Status Not Evaluated [NCIt concept]
- Karnofsky Performance Status Unknown [NCIt concept]
- Leukocyte Count [NCIt concept]
- Local Anesthesia Agents were Administered [NCIt concept]
- Local Anesthesia Agents were not Administered [NCIt concept]
- Loss of Chromosome 13 [NCIt concept]
- Loss of Chromosome 17p [NCIt concept]
- Loss of Chromosome 20q [NCIt concept]
- Loss of Chromosome 5 [NCIt concept]
- Loss of Chromosome 5q [NCIt concept]
- Loss of Chromosome 7 [NCIt concept]
- Loss of Chromosome 7q [NCIt concept]
- Lymphocyte Count [NCIt concept]
- MKI67 Negative [NCIt concept]
- MKI67 Positive [NCIt concept]
- MME Negative [NCIt concept]
- MME Positive [NCIt concept]
- MN1 Gene Mutation [NCIt concept]
- MPL Gene Mutation [NCIt concept]
- MPO Negative [NCIt concept]
- MPO Positive [NCIt concept]
- MPX Negative [NCIt concept]
- MPX Positive [NCIt concept]
- Maintenance Therapy [NCIt concept]
- Metamyelocyte Count [NCIt concept]
- Microgranular Acute Promyelocytic Leukemia [NCIt concept]
- Millimeter per Hour [NCIt concept]
- Mixed Phenotype Acute Leukemia [NCIt concept]
- Molecular Abnormalities Detected [NCIt concept]
- Molecular Abnormalities Not Detected [NCIt concept]
- Molecular Abnormalities Unknown [NCIt concept]
- Monocyte Count [NCIt concept]
- Month [NCIt concept]
- Month-Day-Year [NCIt concept]
- Myelocyte Count [NCIt concept]
- NCAM1 Negative [NCIt concept]
- NCAM1 Positive [NCIt concept]
- Neutrophil Band Form Count [NCIt concept]
- Not Known if Additional Molecular Studies Were Performed [NCIt concept]
- Not Known if Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Performed [NCIt concept]
- Not Known if Fluorescence In Situ Hybridization Was Performed [NCIt concept]
- Not Known if Peripheral Blood Immunophenotyping and Cytochemistry Were Performed [NCIt concept]
- One Hundred Percent [NCIt concept]
- Organ of Origin [NCIt concept]
- Other Cytogenetic Analysis Abnormality Type [NCIt concept]
- Other Molecular Analysis [NCIt concept]
- PAS Negative [NCIt concept]
- PAS Positive [NCIt concept]
- PAX5 Negative [NCIt concept]
- PAX5 Positive [NCIt concept]
- PML-RARA Fusion Protein Expression [NCIt concept]
- PML/RARA Fusion Gene [NCIt concept]
- PTPN11 Gene Mutation [NCIt concept]
- PTPRC Negative [NCIt concept]
- PTPRC Positive [NCIt concept]
- Pathologic/Prognostic Information [NCIt concept]
- Percent Blasts in Peripheral Blood at Diagnosis [NCIt concept]
- Percentage [NCIt concept]
- Performance Status Scale Timing Not Applicable [NCIt concept]
- Performance Status Scale Timing Unknown [NCIt concept]
- Performance Status Scale: Timing [NCIt concept]
- Peripheral Blood [NCIt concept]
- Peripheral Blood Immunophenotype & Cytochemistry [NCIt concept]
- Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed [NCIt concept]
- Peripheral Blood Immunophenotyping and Cytochemistry Were Performed [NCIt concept]
- Platelet Count [NCIt concept]
- Poor CALGB Criteria [NCIt concept]
- Preoperative ECOG - Performance Status [NCIt concept]
- Preoperative Karnofsky Performance Status [NCIt concept]
- Primary Site of Disease [NCIt concept]
- Print, Sign, Date Form [NCIt concept]
- Prolymphocyte Count [NCIt concept]
- Promonocyte Count [NCIt concept]
- Promyelocyte Count [NCIt concept]
- RUNX1 Gene Mutation [NCIt concept]
- RUNX1/RUNX1T1 Fusion Gene [NCIt concept]
- Reinduction Therapy [NCIt concept]
- Remission CALGB Criteria [NCIt concept]
- Reverse Transcriptase-Polymerase Chain Reaction [NCIt concept]
- Routine Cytogenetics Were Completed [NCIt concept]
- Routine Cytogenetics Were not Completed [NCIt concept]
- SBB Negative [NCIt concept]
- SBB Positive [NCIt concept]
- SPN Negative [NCIt concept]
- SPN Positive [NCIt concept]
- Salvage Therapy [NCIt concept]
- Segmented Neutrophil Count [NCIt concept]
- Select One [NCIt concept]
- Southern Blotting [NCIt concept]
- Specify Molecular Abnormalities in Study [NCIt concept]
- Specify Molecular Abnormality Analysis Method [NCIt concept]
- Specify Other Molecular Analysis [NCIt concept]
- Specify if Other Cytogenetic Analysis Abnormality Type [NCIt concept]
- Tissue Source Site [NCIt concept]
- Tissue Source Site Identifier [NCIt concept]
- Total [NCIt concept]
- Total Number of Metaphases [NCIt concept]
- Transcribe Data into CDR and Record the Following [NCIt concept]
- Trisomy 4 [NCIt concept]
- Unknown ECOG Performance Status [NCIt concept]
- Unknown Molecular Analysis [NCIt concept]
- Unknown if Routine Cytogenetics were Completed [NCIt concept]
- WHO AML Classification of Tumors [NCIt concept]
- Was Another CD Antigen Tested [NCIt concept]
- Was Fluorescence In Situ Hybridization Performed [NCIt concept]
- Were Additional Molecular Studies Performed [NCIt concept]
- Were Immunophenotype and Cytochemistry Analyses Performed on Bone Marrow Aspirate [NCIt concept]
- Were Immunophenotype and Cytochemistry Analyses Performed on Peripheral Blood Samples [NCIt concept]
- Were Local Anesthesia Agents Administered [NCIt concept]
- Were Molecular Abnormalities Detected [NCIt concept]
- Were Routine Cytogenetics Completed [NCIt concept]
- What is the Cell Source [NCIt concept]
- What is the Other Performance Status Scale: Timing [NCIt concept]
- XK Negative [NCIt concept]
- XK Positive [NCIt concept]
- Year [NCIt concept]
- inv(16) [NCIt concept]
- inv(3) [NCIt concept]
- t(12;21) [NCIt concept]
- t(15;17) [NCIt concept]
- t(3;3) [NCIt concept]
- t(4;11) [NCIt concept]
- t(6;9) [NCIt concept]
- t(8;21) [NCIt concept]
- t(9;11) [NCIt concept]
- t(9;22) [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients